摘要:
An optically detectable analytical composition comprising a rare earth dopant, a carrier incorporating the rare earth dopant, and at least one of: a chemical linker suitable to bind to a biological binding agent and a biological binding agent is disclosed. Preferred embodiments include a glass micro bead carrier treated to attach a biological binding agent such as a protein, or a nucleic acid. The binding agent can bind to a target species in a sample and thereafter be used to determine the presence, concentration or absence of the target in the sample. The composition can be used in a number of different applications, such as to perform fragment analysis of DNA. The narrow bands emitted by rare earth dopants when excited, allows for a large number of such dopants to be incorporated into an individual carrier, allowing detailed characterisation of the sample to be conducted in a reduced number of sample test runs.
摘要:
Compounds represented by the following general formula (I): R-Y-(-X-Phe-COCH2COCnF2n+1)m (I) wherein R represents hydrogen, alkyl, phenyl or a group capable of binding to a protein, a peptide, an amino acid, a nucleic acid or a base; Y represents CH2, a carbon ring or a heterocycle; X represents O, S, NH, CH2, OCH2, CONH or NHCO; Phe represents phenylene; n is an integer of from 1 to 5; and m is 1, 2 or 3; luminous complexes comprising the above compounds with rare earth ions; labeling reagents comprising the compounds or luminous complexes as described above; and a method of labeling a protein, a peptide, an amino acid, a nucleic acid or a base using the above labeling reagents.
摘要:
The present invention provides detectable compounds comprising a chemically-transformable first compound covalently linked to an electrochemiluminescent compound. These compounds are useful in processes and kits that monitor the status of the first compound and derive information from the monitoring. The figure shows a proposed ECL mechanism depicting reaction steps associated with the use of TPA as a nonconjugated reductant.
摘要:
The invention relates to a process for reducing the fluorescence quenching caused by the measuring medium in a fluorescence assay, by introducing into said medium of rare earth metal cryptates comprising at least one pyrdine radical which is substituted one or more times or unsubstituted. The invetion also relates to novel rare metal cryptates which are not very sensitive to the fluorescence quenching caused by the measuring medium.
摘要:
The invention relates to a method for detection of an analyte in a test sample by a specific binding reaction among the analyte, a specific binding partner for the analyte, and an (immuno)reactant provided with a label, characterized in that the label is a lanthanide ion-ligand complex wherein the lanthanide ion is neodymium(III) ion (Nd3+), ytterbium(III) ion (Yb3+), or erbium(III) ion (Er3+) and the ligand comprises or is in contact with a sensitizing moiety which absorbs in the 400-1000 nm region, and preferably in the 400-800 nm region. Further, a diagnostic kit is disclosed as well as a method of detecting an analyte in a matrix of biomedical interest through an oligonucleotide, an antigen, or an antibody attached to a material, preferably core-shell latex or with specific binding sites wherein the antigen or antibody is labeled with the lanthanide ion-ligand complex and brought into contact with the analyte, after which the analyte with the lanthanide-ion complex is immobilized on the material, and, optionally, residual lanthanide-ion complex is removed, after which the sample obtained is irradiated with light in the 400-1000 nm region, and the emitted light from said sample is detected if said analyte is present in the matrix of biomedical interest.
摘要:
The invention relates to improvements of energy-transfer based homogeneous assays, which use time-resolved fluorometry in detection. The specific improvements relate to the type of lanthanide chelate labels used as energy donors, optimized energy acceptors for defined assays, the way energy transfer is measured using optimized filters and time windows, ways to correct all possible interferences derived from samples, use the assay for multi-component analysis and development of simplified assay protocols.
摘要:
L'invention concerne un procédé de réduction d'interférences dans un dosage par fluorescence d'un analyte caractérisé en ce que l'on ajoute au milieu de mesure des ions fluorures ainsi que son utilisation dans un procédé de détection et/ou de détermination par fluorescence d'un analyte dans un milieu susceptible de le contenir.
摘要:
Method for a homogeneous biospecific affinity assay for determining the content of a substance (analyte) in a biological sample. The assay is carried out in an aqueous reaction medium by means of time-resolved fluorescence spectroscopy and with a biospecific affinity reactant labeled with a lanthanide chelate in which a lanthanide ion exhibiting ionic fluorescence is chelated by a ligand bound covalently to the reactant. The characteristic feature is
(i) that the lanthanide chelate formed by the lanthanide ion together with the covalently bound ligand forms a fluorescent chelate, and (ii) that a modulator is added which stabilizes the lanthanide chelate so that the lanthanide fluorescence as measured from the medium becomes a practically pure function of the analyte concentration therein.